Co-Authors
This is a "connection" page, showing publications co-authored by Toru Hifumi and Norio Otani.
Connection Strength
0.956
-
Tokyo and New York: A Study in the Contrasting Effects of Socioeconomic Status on Coronavirus Disease 2019 Outcomes. Crit Care Explor. 2020 Sep; 2(9):e0221.
Score: 0.226
-
Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients. Crit Care. 2020 08 12; 24(1):497.
Score: 0.224
-
Clinical characteristics and outcomes of critically ill COVID-19 patients in Tokyo: a single-center observational study from the first wave. BMC Infect Dis. 2021 Feb 09; 21(1):163.
Score: 0.058
-
Development of acute kidney injury with massive granular casts and microscopic hematuria in patients with COVID-19: two case presentations with literature review. Ren Replace Ther. 2020; 6(1):59.
Score: 0.057
-
Relationship Between the Number of Patients Visiting Emergency Department and Tokyo Health System's Capacity During Early Stages of the First Wave of COVID-19. SN Compr Clin Med. 2020; 2(11):2158-2160.
Score: 0.057
-
The application of 6S in the care of COVID-19 patients: a Japanese perspective. Crit Care. 2020 09 01; 24(1):542.
Score: 0.056
-
Impaired mental health status following ICU care in a patient with COVID-19. Acute Med Surg. 2020 Aug 11.
Score: 0.056
-
The authors' response: Propofol in COVID 19: From basic science to clinical impact. Am J Emerg Med. 2021 07; 45:528.
Score: 0.056
-
The authors' response: A diagnostic confusion between serotonin syndrome and neuroleptic malignant syndrome. Am J Emerg Med. 2021 05; 43:274.
Score: 0.056
-
The authors' response: Propofol and sedation in patients with coronavirus disease 2019. Am J Emerg Med. 2021 Apr; 42:251.
Score: 0.055
-
Neuroleptic malignant syndrome in patients with COVID-19. Am J Emerg Med. 2020 10; 38(10):2243.e1-2243.e3.
Score: 0.055